Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The CARE-HF trial is an international, open-label, randomized, and controlled trial that was sponsored by Medtronic to evaluate the effects of Cardiac Resynchronization Therapy (CRT) on the mortality and morbidity of patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony already receiving optimal medical therapy.
